Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$167.58
-0.3%
$155.43
$116.88
▼
$176.58
$208.31B0.356.77 million shs4.58 million shs
Microsoft Corporation stock logo
MSFT
Microsoft
$517.99
-1.1%
$519.36
$349.20
▼
$559.15
$3.88T1.0526.17 million shs29.59 million shs
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
$84.85
-1.4%
$84.11
$72.78
▼
$97.76
$257.44B0.9313.48 million shs9.16 million shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
0.00%+0.71%+7.61%+20.99%+34.44%
Microsoft Corporation stock logo
MSFT
Microsoft
0.00%-1.27%-0.98%+9.06%+2.69%
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
0.00%+2.42%+2.62%-1.75%+1.22%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$167.58
-0.3%
$155.43
$116.88
▼
$176.58
$208.31B0.356.77 million shs4.58 million shs
Microsoft Corporation stock logo
MSFT
Microsoft
$517.99
-1.1%
$519.36
$349.20
▼
$559.15
$3.88T1.0526.17 million shs29.59 million shs
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
$84.85
-1.4%
$84.11
$72.78
▼
$97.76
$257.44B0.9313.48 million shs9.16 million shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
0.00%+0.71%+7.61%+20.99%+34.44%
Microsoft Corporation stock logo
MSFT
Microsoft
0.00%-1.27%-0.98%+9.06%+2.69%
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
0.00%+2.42%+2.62%-1.75%+1.22%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
2.79
Moderate Buy$171.632.42% Upside
Microsoft Corporation stock logo
MSFT
Microsoft
2.94
Moderate Buy$609.5417.67% Upside
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
2.65
Moderate Buy$97.5014.92% Upside

Current Analyst Ratings Breakdown

Latest GILD, MSFT, and WFC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/16/2026
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
Boost Price TargetEqual Weight$145.00 ➝ $160.00
11/12/2026
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
Set Price Target$190.00
11/10/2026
Microsoft Corporation stock logo
MSFT
Microsoft
Reiterated RatingOutperform
11/6/2026
Microsoft Corporation stock logo
MSFT
Microsoft
Initiated CoverageBuy
11/4/2026
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
Set Price Target$196.00
11/2/2026
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
Reiterated RatingOutperform$175.00
10/30/2026
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
Boost Price TargetBuy$175.00 ➝ $195.00
10/30/2026
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
Set Price Target$175.00
10/30/2026
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
Boost Price TargetBuy$160.00 ➝ $175.00
10/30/2026
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
Reiterated RatingOutperform$184.00
10/30/2026
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
Boost Price TargetOverweight$170.00 ➝ $190.00
(Data available from 11/16/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$29.44B7.06$10.45 per share16.04$10.44 per share16.05
Microsoft Corporation stock logo
MSFT
Microsoft
$331.84B11.59$22.32 per share23.21$63.36 per share8.18
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
$123.53B2.06$9.17 per share9.25$53.56 per share1.58
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$8.51B-$3.16N/A16.58N/A-12.47%-1.85%-0.61%N/A
Microsoft Corporation stock logo
MSFT
Microsoft
$133.75B$19.1628.9921.761.5441.17%31.28%18.55%1/27/2027 (Estimated)
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
$21.34B$7.0911.9910.580.9217.64%14.05%1.04%1/14/2027 (Estimated)

Latest GILD, MSFT, and WFC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/29/2026Q3 2026
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$2.19$2.55+$0.36$1.94$7.81 billion$8.30 billion
10/28/2026Q1 2027
Microsoft Corporation stock logo
MSFT
Microsoft
$4.72$4.89+$0.17$4.92$90.62 billion$92.28 billion
10/13/2026Q3 2026
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
$1.85$1.87+$0.02$1.87$22.30 billion$21.87 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$3.281.96%+3.04%N/A 10 Years
Microsoft Corporation stock logo
MSFT
Microsoft
$3.640.70%+10.21%19.00%23 Years
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
$2.002.36%+6.86%28.21%4 Years

Latest GILD, MSFT, and WFC Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/27/2026
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
quarterly$0.821.98%12/15/202612/15/202612/30/2026
9/14/2026
Microsoft Corporation stock logo
MSFT
Microsoft
quarterly$0.980.79%11/19/202611/19/202612/10/2026
10/27/2026
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
quarterly$0.502.38%11/6/202611/6/202612/1/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
1.84
1.38
1.22
Microsoft Corporation stock logo
MSFT
Microsoft
0.07
1.22
1.21
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
1.14
0.89
0.89

Institutional Ownership

CompanyInstitutional Ownership
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
83.67%
Microsoft Corporation stock logo
MSFT
Microsoft
71.13%
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
75.90%

Insider Ownership

CompanyInsider Ownership
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
0.30%
Microsoft Corporation stock logo
MSFT
Microsoft
0.03%
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
0.14%
CompanyEmployeesShares OutstandingFree FloatOptionable
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
17,0001.24 billion1.24 billionOptionable
Microsoft Corporation stock logo
MSFT
Microsoft
223,0007.43 billion7.42 billionOptionable
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
205,0003.00 billion3.00 billionOptionable

Recent News About These Companies

Chase and other major banks hit by online outages
Zelle picks Solana for ZelleUSD stablecoin and international payments
Cogent Communications drops after Wells Fargo turns Underweight
Wells Fargo Downgraded Hartford (HIG). What Changed in Commercial?
Wells Fargo & Company Declares Cash Dividends on Preferred Stock
Wells Fargo Eyes $50B NII in 2026: What's Fuelling the Optimism?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Gilead Sciences stock logo

Gilead Sciences NASDAQ:GILD

$167.58 -0.50 (-0.30%)
Closing price 04:00 PM Eastern
Extended Trading
$168.88 +1.29 (+0.77%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company was incorporated in 1987 and is headquartered in Foster City, California.

Microsoft stock logo

Microsoft NASDAQ:MSFT

$517.99 -5.89 (-1.12%)
Closing price 04:00 PM Eastern
Extended Trading
$519.41 +1.42 (+0.27%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Microsoft Corporation develops and supports software, services, devices and solutions worldwide. The Productivity and Business Processes segment offers office, exchange, SharePoint, Microsoft Teams, office 365 Security and Compliance, Microsoft viva, and Microsoft 365 copilot; and office consumer services, such as Microsoft 365 consumer subscriptions, Office licensed on-premises, and other office services. This segment also provides LinkedIn; and dynamics business solutions, including Dynamics 365, a set of intelligent, cloud-based applications across ERP, CRM, power apps, and power automate; and on-premises ERP and CRM applications. The Intelligent Cloud segment offers server products and cloud services, such as azure and other cloud services; SQL and windows server, visual studio, system center, and related client access licenses, as well as nuance and GitHub; and enterprise services including enterprise support services, industry solutions, and nuance professional services. The More Personal Computing segment offers Windows, including windows OEM licensing and other non-volume licensing of the Windows operating system; Windows commercial comprising volume licensing of the Windows operating system, windows cloud services, and other Windows commercial offerings; patent licensing; and windows Internet of Things; and devices, such as surface, HoloLens, and PC accessories. Additionally, this segment provides gaming, which includes Xbox hardware and content, and first- and third-party content; Xbox game pass and other subscriptions, cloud gaming, advertising, third-party disc royalties, and other cloud services; and search and news advertising, which includes Bing, Microsoft News and Edge, and third-party affiliates. The company sells its products through OEMs, distributors, and resellers; and directly through digital marketplaces, online, and retail stores. The company was founded in 1975 and is headquartered in Redmond, Washington.

Wells Fargo & Company stock logo

Wells Fargo & Company NYSE:WFC

$84.84 -1.21 (-1.40%)
Closing price 03:59 PM Eastern
Extended Trading
$84.72 -0.12 (-0.14%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Wells Fargo & Co. is a diversified and community-based financial services company, which engages in the provision of banking, insurance, investments, mortgage, and consumer and commercial finance products and services. It operates through the following segments: Consumer Banking and Lending, Commercial Banking, Corporate and Investment Banking, and Wealth and Investment Management. The Consumer Banking and Lending segment offers consumer and small business banking, home lending, credit cards, auto, and personal lending. The Commercial Banking segment provides banking and credit products across industry sectors and municipalities, secured lending and lease products, and treasury management. The Corporate and Investment Banking segment is composed of corporate banking, investment banking, treasury management, commercial real estate lending and servicing, and equity and fixed income solutions, as well as sales, trading, and research capabilities. The Wealth and Investment Management segment refers to personalized wealth management, brokerage, financial planning, lending, private banking, trust, and fiduciary products and services. The company was founded by Henry Wells and William G. Fargo on March 18, 1852 and is headquartered in San Francisco, CA.